Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage company ...
How Cancer Research Is Advancing in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback